Scientists discover a molecule that shuts down a brain cancer (glioblastoma)-driving gene, offering hope beyond surgery, ...
Attia’s work in longevity medicine was co-signed by Oprah and Gwyneth Paltrow. This week, the bestselling author of “Outlive” ...
Robin “Shyne” Edwards is building more than a brand; she’s cultivating a community rooted in access, visibility, and empowerment. As the founder of Noir, Edwards is reshaping how technology, ...
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, ...
After years of mid-morning energy crashes, I've finally cracked the code on plant-based breakfasts that actually sustain me through my busiest hours.
Oreo's got a fun collaboration with Marvel, Reese's has a new dark chocolate cereal and Shark's launched an at-home facial ...
Researchers found that paired pathogenic variants can restore protein function rather than make it worse. This phenomenon ...
The Phase 1 study of PRT12396 is an open-label, multi-center, safety and efficacy study in patients with high-risk polycythemia vera (PV) and intermediate and high-risk myelofibrosis (MF). The primary ...
Proteins that start life inside neurons build up faster in old age and spread to other brain cells—a potentially source of neurological mischief ...
JBS N.V. remains fundamentally attractive and undervalued, with a Buy rating and a 2026 price target of $18.2/share. JBS's global protein leadership, strong FCF generation, and ongoing deleveraging ...
If you imagine the earliest animals on Earth, you might picture something simple but sturdy. Maybe a sponge-like creature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results